Literature DB >> 9818025

Tumor-specific activation of mitogen-activated protein kinase in human colorectal and gastric carcinoma tissues.

Y Kuno1, K Kondo, H Iwata, T Senga, S Akiyama, K Ito, H Takagi, M Hamaguchi.   

Abstract

To search for the signaling events in colorectal carcinoma relevant to its tumorigenesis, we investigated the activity of mitogen-activated protein kinase (MAPK) in human colorectal carcinoma tissues and paired normal tissues. Of 64 cases examined, approximately 75% (48 cases) showed tumor-specific activation of MAPK by in situ kinase renaturation assay, as well as in vitro kinase assay with immunoprecipitated MAPK. In addition, tumor-specific activation of MAPK was associated with the activation of MAPK kinase in the cases we examined. However, no clear correlation of MAPK activation with lymph node involvement, metastatic rate, stage, histological classification, age or sex was observed. These results suggest that the MAPK pathway is involved in colorectal tumor development, but its activation alone is not sufficient for malignant conversion. In contrast to colorectal carcinoma, gastric carcinoma tissues showed a lower rate of MAPK activation, suggesting that the signaling pathway activated in colorectal carcinoma tissues may differ in part from that of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818025      PMCID: PMC5921942          DOI: 10.1111/j.1349-7006.1998.tb00647.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  28 in total

Review 1.  Signal transduction via the MAP kinases: proceed at your own RSK.

Authors:  J Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

2.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

3.  Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells.

Authors:  K Shibata; F Kikkawa; A Nawa; A A Thant; K Naruse; S Mizutani; M Hamaguchi
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

4.  Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.

Authors:  R Seshadri; F A Firgaira; D J Horsfall; K McCaul; V Setlur; P Kitchen
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

5.  Complementation of byr1 in fission yeast by mammalian MAP kinase kinase requires coexpression of Raf kinase.

Authors:  D A Hughes; A Ashworth; C J Marshall
Journal:  Nature       Date:  1993-07-22       Impact factor: 49.962

6.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro.

Authors:  P Dent; W Haser; T A Haystead; L A Vincent; T M Roberts; T W Sturgill
Journal:  Science       Date:  1992-09-04       Impact factor: 47.728

7.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Authors:  A Berchuck; A Kamel; R Whitaker; B Kerns; G Olt; R Kinney; J T Soper; R Dodge; D L Clarke-Pearson; P Marks
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

8.  p185neu expression in human lung adenocarcinomas predicts shortened survival.

Authors:  J A Kern; D A Schwartz; J E Nordberg; D B Weiner; M I Greene; L Torney; R A Robinson
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

9.  p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system.

Authors:  M Hamaguchi; N Matsuyoshi; Y Ohnishi; B Gotoh; M Takeichi; Y Nagai
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

10.  Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis.

Authors:  M Nishimura; K Machida; M Imaizumi; T Abe; T Umeda; E Takeshima; T Watanabe; Y Ohnishi; K Takagi; M Hamaguchi
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

View more
  6 in total

1.  Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells.

Authors:  R Minelli; L Serpe; P Pettazzoni; V Minero; G Barrera; Cl Gigliotti; R Mesturini; A C Rosa; P Gasco; N Vivenza; E Muntoni; R Fantozzi; U Dianzani; G P Zara; C Dianzani
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.

Authors:  Sébastien Bergeron; Etienne Lemieux; Véronique Durand; Sébastien Cagnol; Julie C Carrier; Jacques G Lussier; Marie-Josée Boucher; Nathalie Rivard
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

3.  Prognostic value of RKIP and p-ERK in gastric cancer.

Authors:  Yoshitaka Fujimori; Mikito Inokuchi; Yoko Takagi; Keiji Kato; Kazuyuki Kojima; Kenichi Sugihara
Journal:  J Exp Clin Cancer Res       Date:  2012-03-31

4.  Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.

Authors:  Koga Komatsu; F Gregory Buchanan; Michiro Otaka; Mario Jin; Masaru Odashima; Yohei Horikawa; Sumio Watanabe; Raymond N Dubois
Journal:  Mol Cancer       Date:  2006-11-17       Impact factor: 27.401

5.  Inhibition of p38 MAPK increases the sensitivity of 5-fluorouracil-resistant SW480 human colon cancer cells to noscapine.

Authors:  Zheng Han; Liu Meng; Xiaodong Huang; Jie Tan; Weijie Liu; Wei Chen; Yanli Zou; Yishan Cai; Shasha Huang; Aifang Chen; Ting Zhan; Min Huang; Xiaoli Chen; Xia Tian; Qingxi Zhu
Journal:  Oncol Lett       Date:  2021-12-17       Impact factor: 2.967

6.  KRAS mutation-independent downregulation of MAPK/PI3K signaling in colorectal cancer.

Authors:  Kuen Kuen Lam; Choong Leong Tang; Emile Tan; Siew Heng Wong; Peh Yean Cheah
Journal:  Mol Oncol       Date:  2022-01-01       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.